Your browser doesn't support javascript.
loading
Syndrome of inappropriate secretion of antidiuretic hormone following high dose rate brachytherapy for prostate cancer: a case report.
Ayoola, Adeoluwa; Sodji, Quaovi H; Chin, Sharon; Panousis, Periklis; Bagshaw, Hilary P; Buyyounouski, Mark K.
Affiliation
  • Ayoola A; Stanford University School of Medicine, Stanford, CA, USA.
  • Sodji QH; Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA. qsodji@stanford.edu.
  • Chin S; Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.
  • Panousis P; Department of Anesthesiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Bagshaw HP; Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.
  • Buyyounouski MK; Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.
BMC Urol ; 22(1): 32, 2022 Mar 10.
Article in En | MEDLINE | ID: mdl-35272646
ABSTRACT

BACKGROUND:

The syndrome of inappropriate secretion of antidiuretic hormone is a disorder characterized by the excess release of antidiuretic hormone and can result in hyponatremia. If managed inappropriately, severe hyponatremia can cause seizures, cerebral edema, and even death. There are various known causes of this inappropriate release of antidiuretic hormone, including malignancy, CNS disorders, and disturbances in the hypothalamic-pituitary-renal axis. However, reports of syndrome of inappropriate secretion of antidiuretic hormone after brachytherapy for prostate cancer are exceedingly rare. CASE PRESENTATION We report a case of symptomatic hyponatremia secondary to the inappropriate secretion of antidiuretic hormone after prostate high-dose rate brachytherapy under general anesthesia in a patient with adenocarcinoma of the prostate.

CONCLUSIONS:

In rare instances, inappropriate secretion of antidiuretic hormone can occur after high-dose rate brachytherapy for prostate cancer. The cause is likely multifactorial, involving pain or discomfort ensuing from the surgical procedure, the general anesthesia or intraoperative drugs administered. However, due to the potential severity of the side effects, timely diagnosis is crucial to ensure prompt, and effective management.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Brachytherapy / Adenocarcinoma / Inappropriate ADH Syndrome Type of study: Etiology_studies Limits: Aged / Humans / Male Language: En Journal: BMC Urol Journal subject: UROLOGIA Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Brachytherapy / Adenocarcinoma / Inappropriate ADH Syndrome Type of study: Etiology_studies Limits: Aged / Humans / Male Language: En Journal: BMC Urol Journal subject: UROLOGIA Year: 2022 Type: Article Affiliation country: United States